Pacira | PCRX - Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
Astellas Pharma JPY 281.6B 93.23B 2026-03
Bristol-Myers Squibb USD 8.72B 852M 2026-06
Cara Therapeutics USD 19.85M 883K 2026-03
Coherus Biosciences USD 82.92M 32.32M 2026-06
Heron Therapeutics USD 20.72M 5.4M 2026-06
Ironwood Pharmaceuticals USD 220.47M 5.01M 2026-03
J&J USD 20.42B 1.27B 2026-06
Ligand Pharmaceuticals USD 1.01B 891.62M 2026-06
Nektar Therapeutics USD 149.58M 134.46M 2026-03
Novo Nordisk A/S DKK 18.44B 5.78B 2025-06
Omeros USD 1.9M 2.36M 2025-06
Pacira USD 205.88M 61.57M 2026-06
Perrigo USD 357.2M 174.4M 2026-03
Pfizer USD 976M 727M 2026-06
Supernus Pharmaceuticals USD 179.95M 4.92M 2026-06
Teva Pharmaceutical Industries USD 3.74B 185M 2026-03
Xeris Pharmaceuticals USD 121.75M 10M 2026-06
Zoetis USD 1.48B 465M 2026-06